HIF1A and metabolic process: In summary, HIF-1α protected against IVDD, possibly through reducing ROS production in the mitochondria and consequent inhibition of inflammation, metabolism disorders and apoptosis of NP cells, which provided a new idea for exploring the therapeutic strategies and targeted drugs for IVDD (Fig. 6).